FYREMADEL 0.25 mg/0.5 ml, solution for injection in a pre-filled syringe 5 syringes of 0.5 ml
Active ingredients: Ganirelix acetate, Ganirelix
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injection5 syringes of 0.5 mlsous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- FYREMADEL 0,25 mg/0,5 mL, solution injectable en seringue pré-remplie
- Pharmaceutical form
- solution injectable
- Route of administration
- sous-cutanée
- Presentation description
- 5 seringue(s) préremplie(s) en verre de 0,5 ml munie d'une aiguille d'injection
- Marketing authorisation holder
- SUN PHARMACEUTICAL INDUSTRIES EUROPE (PAYS BAS)
- Reimbursement according to BDPM
- 100%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 25 Sept 2017
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
61462270CIP72751710CIP133400927517105Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| GANIRÉLIXsolution | 0,25 mg · une seringue pré-remplie de 0,5 mL | FT |
| ACÉTATE DE GANIRÉLIXsolution | — | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.